A securities class action lawsuit has been filed against Regencell Bioscience Holdings Limited in the U.S. District Court for the District of Maryland. The lawsuit alleges that Regencell failed to disclose its vulnerability to market manipulation and the resulting volatility, which exposed investors to significant financial risks. It also claims that these issues increased the company's risk of regulatory scrutiny and legal harm, making the company's public statements false and misleading. Investors who bought Regencell shares between October 28, 2024, and October 31, 2025, are encouraged to contact the law firm before the June 23, 2026 deadline to participate in the case.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) has outperformed Bitcoin (BTC) in Q3, driven by a rally sparked by a softer CPI report and strong on-chain metrics. The recent surge pushed ETH above $1,900, triggering significant liquidations in futures positions. However, ETH now fa...
Solana's number of wallets holding tokenized real-world assets (RWAs) has exceeded 300,000, surpassing Ethereum's roughly 200,000 holders. While Solana's RWA value doubled in 2026 to $3.45 billion, Ethereum still leads with $16.3 billion in tokenized...
Baidu's board has approved a plan to convert to a dual-primary listing on the Hong Kong Stock Exchange's Main Board, alongside its existing Nasdaq listing. This move aims to enhance the liquidity of Baidu's shares, broaden its investor base, and prov...
